DOP2012000243A - Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades virales - Google Patents
Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades viralesInfo
- Publication number
- DOP2012000243A DOP2012000243A DO2012000243A DO2012000243A DOP2012000243A DO P2012000243 A DOP2012000243 A DO P2012000243A DO 2012000243 A DO2012000243 A DO 2012000243A DO 2012000243 A DO2012000243 A DO 2012000243A DO P2012000243 A DOP2012000243 A DO P2012000243A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- sililo
- compounds
- fusioned
- tricyclic
- same
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0816—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS COMPUESTOS DE SILILO TRICÍCLICOS FUSIONADOS DE FÓRMULA (I): Y SALES FARMACÉUTICAMENTE ACEPTABLES DE LOS MISMOS, EN DONDE A, B, C, D, M1, X1 Y X2 SON COMO SE DEFINEN EN EL PRESENTE DOCUMENTO. LA PRESENTE INVENCIÓN TAMBIÉN SE REFIERE A COMPOSICIONES QUE COMPRENDEN AL MENOS UN COMPUESTO DE SILILO TRICÍCLICO FUSIONADO, Y A MÉTODOS DE USO DE LOS COMPUESTOS DE SILILO TRICÍCLICOS FUSIONADOS PARA TRATAR O PREVENIR UNA INFECCIÓN POR VHC EN UN PACIENTE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31201610P | 2010-03-09 | 2010-03-09 | |
US37193510P | 2010-08-09 | 2010-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2012000243A true DOP2012000243A (es) | 2012-12-31 |
Family
ID=43939669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2012000243A DOP2012000243A (es) | 2010-03-09 | 2012-09-07 | Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades virales |
Country Status (25)
Country | Link |
---|---|
US (1) | US8609635B2 (es) |
EP (1) | EP2545060B1 (es) |
JP (1) | JP2013522202A (es) |
KR (1) | KR20130008040A (es) |
CN (1) | CN102918049A (es) |
AR (1) | AR080676A1 (es) |
AU (1) | AU2011224698A1 (es) |
BR (1) | BR112012022125A2 (es) |
CA (1) | CA2792121A1 (es) |
CL (1) | CL2012002489A1 (es) |
CO (1) | CO6592102A2 (es) |
CR (1) | CR20120460A (es) |
DO (1) | DOP2012000243A (es) |
EA (1) | EA201290882A1 (es) |
EC (1) | ECSP12012147A (es) |
ES (1) | ES2558554T3 (es) |
MA (1) | MA34147B1 (es) |
MX (1) | MX2012010392A (es) |
NI (1) | NI201200139A (es) |
PE (1) | PE20130062A1 (es) |
SG (1) | SG183526A1 (es) |
TN (1) | TN2012000416A1 (es) |
TW (1) | TW201136943A (es) |
WO (1) | WO2011112429A1 (es) |
ZA (1) | ZA201206716B (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2740195A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
CA2740193A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
US20190127365A1 (en) | 2017-11-01 | 2019-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
SI2410844T1 (sl) | 2009-03-27 | 2016-06-30 | Merck Sharp & Dohme Corp. | Inhibitorji replikacije virusa hepatitisa C |
JP5734956B2 (ja) * | 2009-04-15 | 2015-06-17 | アッヴィ・インコーポレイテッド | 抗ウィルス化合物 |
EP2430015B1 (en) | 2009-05-12 | 2015-06-17 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds useful for the treatment of viral diseases |
US8088368B2 (en) | 2009-05-13 | 2012-01-03 | Gilead Sciences, Inc. | Antiviral compounds |
EP2435424B1 (en) | 2009-05-29 | 2015-01-21 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c |
WO2010138790A1 (en) | 2009-05-29 | 2010-12-02 | Schering Corporation | Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c |
US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
RS53856B1 (en) | 2009-06-11 | 2015-08-31 | Abbvie Bahamas Ltd. | HETEROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS |
US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
US8354419B2 (en) | 2009-07-16 | 2013-01-15 | Vertex Pharmaceuticals Incorporated | Benzimidazole analogues for the treatment or prevention of flavivirus infections |
US20130156731A1 (en) * | 2009-12-22 | 2013-06-20 | Kevin X. Chen | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
JP2013522202A (ja) | 2010-03-09 | 2013-06-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法 |
CN102869657A (zh) | 2010-03-24 | 2013-01-09 | 沃泰克斯药物股份有限公司 | 用于治疗或预防黄病毒感染的类似物 |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
EP2616461A4 (en) | 2010-08-26 | 2014-03-26 | Rfs Pharma Llc | POWERFUL AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS |
AU2011314168A1 (en) | 2010-09-29 | 2013-04-04 | Merck Sharp & Dohme Corp. | Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases |
WO2012050850A1 (en) * | 2010-09-29 | 2012-04-19 | Merck Sharp & Dohme Corp. | Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases |
CA2815537A1 (en) | 2010-10-26 | 2012-05-03 | Presidio Pharmaceuticals, Inc. | Inhibitors of hepatitis c virus |
SG190785A1 (en) | 2010-11-17 | 2013-07-31 | Gilead Sciences Inc | Antiviral compounds |
US8552047B2 (en) | 2011-02-07 | 2013-10-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2012122716A1 (en) | 2011-03-17 | 2012-09-20 | Merck Sharp & Dohme Corp. | Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases |
US9546160B2 (en) * | 2011-05-12 | 2017-01-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
WO2013030750A1 (en) | 2011-09-01 | 2013-03-07 | Lupin Limited | Antiviral compounds |
US20150057246A1 (en) * | 2011-09-14 | 2015-02-26 | Michael P. Dwyer | Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
HUE036588T2 (hu) | 2011-09-16 | 2018-07-30 | Gilead Pharmasset Llc | Eljárások HCV kezelésére |
MD4521C1 (ro) | 2011-11-16 | 2018-05-31 | Gilead Pharmasset Llc. | Compuşi antivirali pe bază de imidazolil-dihidroizocromeno-naftoimidazoli condensaţi |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
US9326973B2 (en) | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
NZ628515A (en) | 2012-02-10 | 2016-06-24 | Lupin Ltd | Antiviral compounds with a dibenzooxaheterocycle moiety |
US9066944B2 (en) | 2012-04-25 | 2015-06-30 | Theravance Biopharma R&D Ip, Llc | Hepatitis C virus inhibitors |
SI2850075T1 (sl) | 2012-04-25 | 2017-06-30 | Theravance Biopharma R&D Ip, Llc | Piperazin-piperidinske spojine kot inhibitorji virusa hepatitisa C |
US20130309196A1 (en) | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
WO2014110687A1 (en) | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
MY172166A (en) | 2013-01-31 | 2019-11-15 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
US20150023913A1 (en) | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
WO2015009744A1 (en) | 2013-07-17 | 2015-01-22 | Bristol-Myers Squibb Company | Combinations comprising biphenyl derivatives for use in the treatment of hcv |
EP4005560A1 (en) | 2013-08-27 | 2022-06-01 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
US10617675B2 (en) | 2015-08-06 | 2020-04-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2017197036A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Spirocyclic degronimers for target protein degradation |
CN109641874A (zh) | 2016-05-10 | 2019-04-16 | C4医药公司 | 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体 |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
WO2018171660A1 (zh) * | 2017-03-22 | 2018-09-27 | 正大天晴药业集团股份有限公司 | 用于抗丙型肝炎病毒感染的含硅化合物 |
CN112679365A (zh) * | 2021-03-15 | 2021-04-20 | 南京桦冠生物技术有限公司 | 一种6-溴萘-1,2-二胺的工业化制备方法 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU575854B2 (en) | 1983-10-04 | 1988-08-11 | Shionogi & Co., Ltd. | 7beta-(carboxyalkenamido) cephalosporins |
NZ220764A (en) | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
US5017380A (en) | 1986-07-02 | 1991-05-21 | Shionogi & Co., Ltd. | Gelatin hard capsule containing crystalline hydrate of oral cephalosporin |
ES2012739T5 (es) | 1987-11-18 | 2001-12-01 | Chiron Corp | Diagnosticos para nanbv. |
ATE132182T1 (de) | 1989-02-01 | 1996-01-15 | Asahi Glass Co Ltd | Azeotrope oder azeotropähnliche zusammensetzung auf der basis von chlorfluorkohlenwasserstoffen |
US5922757A (en) | 1996-09-30 | 1999-07-13 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
IL129407A0 (en) | 1996-10-18 | 2000-02-17 | Vertex Pharma | Inhibitors of serine proteases particularly hepatitis C virus NS3 protease pharmaceutical compositions containing the same and the use thereof |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
US5935982A (en) | 1997-02-28 | 1999-08-10 | The University Of North Carolina At Chapel Hill | Methods of treating retroviral infection and compounds useful therefor |
US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
AU757072B2 (en) | 1997-08-11 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptide analogues |
US6183121B1 (en) | 1997-08-14 | 2001-02-06 | Vertex Pharmaceuticals Inc. | Hepatitis C virus helicase crystals and coordinates that define helicase binding pockets |
AU1099000A (en) | 1998-10-05 | 2000-04-26 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating hepatitis c infections |
CN1623984A (zh) | 1999-12-27 | 2005-06-08 | 日本烟草产业株式会社 | 稠环化合物及其药物用途 |
PT1268519E (pt) | 2000-04-03 | 2005-08-31 | Vertex Pharma | Inibidores de serina protease, particularmente protease ns3 do virus da hepatite c |
KR20030036152A (ko) | 2000-04-05 | 2003-05-09 | 쉐링 코포레이션 | N-사이클릭 p2 잔기를 포함하는 c형 간염 바이러스의매크로사이클릭 ns3-세린 프로테아제 억제제 |
MXPA02010375A (es) | 2000-04-19 | 2003-04-25 | Schering Corp | Inhibidores macrociclicos de la ns3-serina proteasa del virus de la hepatitis c que comprenden porciones alquil y arilalanina p2. |
HUP0303358A3 (en) | 2000-07-21 | 2005-10-28 | Schering Corp | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus and pharmaceutical compositions containing them |
JP4298289B2 (ja) | 2000-07-21 | 2009-07-15 | シェーリング コーポレイション | C型肝炎ウイルスのns3−セリンプロテアーゼ阻害剤としての新規ペプチド |
US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
WO2002008251A2 (en) | 2000-07-21 | 2002-01-31 | Corvas International, Inc. | Peptides as ns3-serine protease inhibitors of hepatitis c virus |
AR034127A1 (es) | 2000-07-21 | 2004-02-04 | Schering Corp | Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento |
WO2002024667A1 (en) | 2000-09-20 | 2002-03-28 | Merck Patent Gmbh | 4-amino-quinazolines |
AU2002236591B2 (en) | 2000-12-12 | 2005-07-14 | Schering Corporation | Diaryl peptides as NS3-serine protease inhibitors of hepatits C virus |
US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
EP1404704B9 (en) | 2001-07-11 | 2008-02-20 | Vertex Pharmaceuticals Incorporated | Bridged bicyclic serine protease inhibitors |
KR20040077767A (ko) | 2002-01-23 | 2004-09-06 | 쉐링 코포레이션 | C형 간염 바이러스 감염 치료용 ns3-세린 프로테아제억제제로서의 프롤린 화합물 |
WO2003087092A2 (en) | 2002-04-11 | 2003-10-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
EP2325226A1 (en) | 2002-10-30 | 2011-05-25 | Sumitomo Chemical Company, Limited | Complex aryl copolymer compounds and polymer light emitting devices made by using the same |
AP2005003319A0 (en) | 2002-11-19 | 2005-06-30 | Achillion Pharmaceitucals Inc | Substituted aryl thioureas and related compounds; inhibitors of viral replication |
AU2004230946A1 (en) | 2003-04-11 | 2004-10-28 | Vertex Pharmaceuticals, Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
JP4527722B2 (ja) | 2003-08-26 | 2010-08-18 | シェーリング コーポレイション | C型肝炎ウイルスの新規のペプチド模倣性ns3−セリンプロテアーゼインヒビター |
EP1660511B1 (en) | 2003-08-27 | 2010-11-03 | Biota Scientific Management Pty. Ltd. | Novel tricyclic nucleosides or nucleotides as therapeutic agents |
RU2006113880A (ru) | 2003-09-26 | 2007-11-20 | Шеринг Корпорейшн (US) | Макроциклические ингибиторы сериновой протеиназы ns3 вируса гепатита с |
US7365092B2 (en) | 2003-10-10 | 2008-04-29 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
AR046833A1 (es) | 2003-11-10 | 2005-12-28 | Schering Corp | Anticuerpos anti-interleuquina-10 |
CN1902216A (zh) | 2003-11-20 | 2007-01-24 | 先灵公司 | 丙肝病毒ns3蛋白酶的去肽化抑制剂 |
EP1742913A1 (en) | 2003-12-11 | 2007-01-17 | Schering Corporation | Inhibitors of hepatitis c virus ns3/ns4a serine protease |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
TW200602037A (en) | 2004-02-27 | 2006-01-16 | Schering Corp | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
US7816326B2 (en) | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
CA2557249A1 (en) | 2004-02-27 | 2005-09-22 | Schering Corporation | Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
AU2005219824B2 (en) | 2004-02-27 | 2007-11-29 | Merck Sharp & Dohme Corp. | Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
US8067379B2 (en) | 2004-02-27 | 2011-11-29 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
US7635694B2 (en) | 2004-02-27 | 2009-12-22 | Schering Corporation | Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
AU2005219859A1 (en) | 2004-02-27 | 2005-09-15 | Schering Corporation | Inhibitors of hepatitis C virus NS3 protease |
DE602005015834D1 (de) | 2004-02-27 | 2009-09-17 | Schering Corp | 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus |
WO2005107745A1 (en) | 2004-05-06 | 2005-11-17 | Schering Corporation | An inhibitor of hepatitis c |
EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
WO2006019832A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US20090081636A1 (en) | 2005-04-11 | 2009-03-26 | Mingjun Huang | Pharmaceutical compositions for and methods of inhibiting HCV replication |
US7994360B2 (en) | 2005-05-16 | 2011-08-09 | Xtl Biopharmaceuticals Ltd. | Benzofuran compounds |
US8143288B2 (en) | 2005-06-06 | 2012-03-27 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US7473784B2 (en) | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
CA2641859A1 (en) | 2006-02-09 | 2007-08-16 | Schering Corporation | Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
US7659270B2 (en) | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8303944B2 (en) | 2006-08-11 | 2012-11-06 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7759495B2 (en) | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
JP2010510245A (ja) | 2006-11-21 | 2010-04-02 | スミスクライン ビーチャム コーポレーション | 抗ウイルス化合物 |
CA2673249C (en) | 2006-12-22 | 2013-04-30 | Schering Corporation | 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
CN101611025A (zh) | 2006-12-22 | 2009-12-23 | 先灵公司 | 5,6-环化的吲哚衍生物及其使用方法 |
WO2008082488A1 (en) | 2006-12-22 | 2008-07-10 | Schering Corporation | 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
WO2008083352A1 (en) | 2006-12-29 | 2008-07-10 | Genifuel Corporation | Production of biofuels using algae |
US20100087382A1 (en) | 2007-02-16 | 2010-04-08 | Boehringer Ingelheim International Gmbh | Inhibitors of Hepatitis C NS3 Protease |
US7741347B2 (en) | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
DE102007033524A1 (de) | 2007-07-19 | 2009-01-22 | Bayer Materialscience Ag | Regeneration eines mit Hexachlorostannat beladenen Anionenaustauschers |
US8404845B2 (en) | 2007-08-29 | 2013-03-26 | Merck Sharp & Dohme Corp. | 2,3-substituted azaindole derivatives for treating viral infections |
TW200924780A (en) | 2007-08-29 | 2009-06-16 | Schering Corp | 2-carboxy substituted indole derivatives and methods of use thereof |
TW200918536A (en) | 2007-08-29 | 2009-05-01 | Schering Corp | Tetracyclic indole derivatives and methods of use thereof |
CA2697375A1 (en) | 2007-08-29 | 2009-03-12 | Schering Corporation | 2, 3-substituted indole derivatives for treating viral infections |
CN101462999A (zh) | 2007-12-21 | 2009-06-24 | 上海药明康德新药开发有限公司 | 氟代或二氟代-2-氮杂双环[2.2.1]庚烷-3-羧酸衍生物及制备方法 |
US7704992B2 (en) | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8147818B2 (en) * | 2008-02-13 | 2012-04-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7906655B2 (en) | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
BRPI0922364A2 (pt) | 2008-12-03 | 2017-08-29 | Presidio Pharmaceuticals Inc | Composto, composição farmacêutica e uso de um composto |
EP2682393A1 (en) | 2008-12-03 | 2014-01-08 | Presidio Pharmaceuticals, Inc. | Inhibitors of HCV NS5A comprising a bicyclic core. |
US8420686B2 (en) | 2009-02-17 | 2013-04-16 | Enanta Pharmaceuticals, Inc. | Linked diimidazole antivirals |
CA2753313A1 (en) | 2009-02-23 | 2010-08-26 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
US8426458B2 (en) | 2009-02-27 | 2013-04-23 | Enanta Pharmaceuticals, Inc. | Hepatitis C Virus inhibitors |
US8101643B2 (en) | 2009-02-27 | 2012-01-24 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
SI2410844T1 (sl) | 2009-03-27 | 2016-06-30 | Merck Sharp & Dohme Corp. | Inhibitorji replikacije virusa hepatitisa C |
EP2430015B1 (en) | 2009-05-12 | 2015-06-17 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds useful for the treatment of viral diseases |
WO2010138790A1 (en) | 2009-05-29 | 2010-12-02 | Schering Corporation | Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c |
EP2435424B1 (en) | 2009-05-29 | 2015-01-21 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c |
US8221737B2 (en) | 2009-06-16 | 2012-07-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
JP2013512246A (ja) | 2009-11-25 | 2013-04-11 | メルク・シャープ・アンド・ドーム・コーポレーション | ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体 |
US8377980B2 (en) | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US20130156731A1 (en) | 2009-12-22 | 2013-06-20 | Kevin X. Chen | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
JP2013522202A (ja) | 2010-03-09 | 2013-06-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法 |
-
2011
- 2011-03-04 JP JP2012557114A patent/JP2013522202A/ja not_active Withdrawn
- 2011-03-04 PE PE2012001466A patent/PE20130062A1/es not_active Application Discontinuation
- 2011-03-04 CN CN2011800233538A patent/CN102918049A/zh active Pending
- 2011-03-04 EP EP11707763.6A patent/EP2545060B1/en active Active
- 2011-03-04 AR ARP110100696A patent/AR080676A1/es unknown
- 2011-03-04 WO PCT/US2011/027117 patent/WO2011112429A1/en active Application Filing
- 2011-03-04 ES ES11707763.6T patent/ES2558554T3/es active Active
- 2011-03-04 EA EA201290882A patent/EA201290882A1/ru unknown
- 2011-03-04 CA CA2792121A patent/CA2792121A1/en not_active Abandoned
- 2011-03-04 KR KR1020127026331A patent/KR20130008040A/ko not_active Application Discontinuation
- 2011-03-04 BR BR112012022125A patent/BR112012022125A2/pt not_active IP Right Cessation
- 2011-03-04 MX MX2012010392A patent/MX2012010392A/es active IP Right Grant
- 2011-03-04 MA MA35291A patent/MA34147B1/fr unknown
- 2011-03-04 US US13/041,082 patent/US8609635B2/en active Active
- 2011-03-04 AU AU2011224698A patent/AU2011224698A1/en not_active Abandoned
- 2011-03-04 SG SG2012063780A patent/SG183526A1/en unknown
- 2011-03-08 TW TW100107798A patent/TW201136943A/zh unknown
-
2012
- 2012-08-15 TN TNP2012000416A patent/TN2012000416A1/en unknown
- 2012-09-07 CL CL2012002489A patent/CL2012002489A1/es unknown
- 2012-09-07 NI NI201200139A patent/NI201200139A/es unknown
- 2012-09-07 ZA ZA2012/06716A patent/ZA201206716B/en unknown
- 2012-09-07 DO DO2012000243A patent/DOP2012000243A/es unknown
- 2012-09-10 EC ECSP12012147 patent/ECSP12012147A/es unknown
- 2012-09-10 CR CR20120460A patent/CR20120460A/es unknown
- 2012-09-10 CO CO12155041A patent/CO6592102A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20130062A1 (es) | 2013-02-28 |
EP2545060B1 (en) | 2015-11-25 |
CO6592102A2 (es) | 2013-01-02 |
KR20130008040A (ko) | 2013-01-21 |
US8609635B2 (en) | 2013-12-17 |
TN2012000416A1 (en) | 2014-01-30 |
WO2011112429A1 (en) | 2011-09-15 |
CA2792121A1 (en) | 2011-09-15 |
SG183526A1 (en) | 2012-09-27 |
AR080676A1 (es) | 2012-05-02 |
CL2012002489A1 (es) | 2012-11-30 |
CN102918049A (zh) | 2013-02-06 |
BR112012022125A2 (pt) | 2016-11-01 |
CR20120460A (es) | 2012-11-01 |
ES2558554T3 (es) | 2016-02-05 |
ECSP12012147A (es) | 2012-10-30 |
NI201200139A (es) | 2013-01-24 |
AU2011224698A1 (en) | 2012-11-01 |
MX2012010392A (es) | 2012-10-03 |
ZA201206716B (en) | 2013-05-29 |
TW201136943A (en) | 2011-11-01 |
EP2545060A1 (en) | 2013-01-16 |
MA34147B1 (fr) | 2013-04-03 |
US20110223134A1 (en) | 2011-09-15 |
JP2013522202A (ja) | 2013-06-13 |
EA201290882A1 (ru) | 2013-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2012000243A (es) | Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades virales | |
ECSP13013019A (es) | Derivados de nucleósidos 2'- sustituidos y métodos de uso de los mismos para el tratamiento de enfermedades virales | |
CY1120031T1 (el) | Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης | |
ECSP15035530A (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas | |
ECSP12012067A (es) | Inhibidores del virus de la hepatitis c | |
CO6561783A2 (es) | Inhibidores del virus flaviviridae | |
CO2017013708A2 (es) | Macrociclos peptídicos contra acinetobacter baumannii. | |
EA201890236A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
CO6960552A2 (es) | Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1 | |
CR20150085A (es) | Nuevas 6-aminoacido-heteroarildihidropirmidindas para el tratamiento y profilaxis de la infección del virus de la hepatitis b | |
CR20160518A (es) | Compuestos para tratar atrofia muscular espinal | |
MX355267B (es) | Análogos de carba-nucleósido 2´-sustituidos para tratamiento antivírico. | |
CR20130560A (es) | Compuestos de bezotiazol y su uso farmacéutico | |
UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
CO6470845A2 (es) | Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales | |
DOP2014000008A (es) | 4-imidazopiridazina-1-il-benzamidas y 4-imidazotriazina-1-il-benzamidas como inhibidores de btk | |
CY1118399T1 (el) | Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c | |
EA200970849A1 (ru) | Трициклические производные изохинолина для лечения ожирения | |
EA201290229A1 (ru) | Производные спиролактама и их применение | |
BR112015000392A2 (pt) | novos indazóis para o tratamento e profilaxia da infecção por vírus sincicial respiratório | |
ECSP12012110A (es) | 5-alquinil-pirimidinas | |
ECSP11011464A (es) | Tia-triaza-ciclopentazulenos | |
CR20140273A (es) | Composiciones y métodos para tratar el virus de la hepatitis c | |
CO6290680A2 (es) | Inhibidores de virus de la hepatitis c |